Atezolizumab and Recombinant Human Hyaluronidase Clinical Trials

1 actively recruiting trial across 1 location

No change since August 2026

Also known as: Atezolizumab + rHuPH20, Atezolizumab and Hyaluronidase, Atezolizumab and Hyaluronidase-tqjs, Atezolizumab and Recombinant Human Hyaluronidase-tqjs, Atezolizumab with rHuPH20 +6 more

Pipeline

Phase 3: 1

Top Sponsors

National Cancer Institute (NCI)1

Indications

Lung Non-Small Cell Carcinoma1
Lung Cancer1
Cancer1

Beverly Hills, California1 trial

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Tower Cancer Research Foundation

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.